Tissue transglutaminase: A novel therapeutic target in cerebral amyloid angiopathy

Neurodegenerative Diseases

Volumn 10, Issue 1-4, 2012, Pages 317-319

  Wilhelmus, Micha M M ^a   De Jager, Mieke ^a   Drukarch, Benjamin ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Cerebral amyloid angiopathy; Extracellular matrix; Tissue transglutaminase

Indexed keywords

AMYLOID BETA PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SCLEROPROTEIN;

ARTICLE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FOLLOW UP; HUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN TRANSPORT; VASCULAR AMYLOIDOSIS;

AMYLOID BETA-PEPTIDES; BASEMENT MEMBRANE; CEREBRAL AMYLOID ANGIOPATHY; HUMANS; TRANSGLUTAMINASES;

EID: 84860214810     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000333224     Document Type: Article

References (18)

1. Hardy J, Allsop D: Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991; 12: 383-388.
2. Wilhelmus MM, de Waal RM, Verbeek MM: Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease. Mol Neurobiol 2007; 35: 203-216.
3. Thal DR, Ghebremedhin E, Orantes M, Wiestler OD: Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 2003; 62: 1287-1301.
4. Deane R, Du YS, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B: RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 2003; 9: 907-913.
5. Carare RO, Bernardes-Silva M, Newman TA, Page AM, Nicoll JA, Perry VH, Weller RO: Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol 2008; 34: 131-144.
6. Schley D, Carare-Nnadi R, Please CP, Perry VH, Weller RO: Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol 2006; 238: 962-974.
7. Weller RO, Subash M, Preston SD, Mazanti I, Carare RO: Perivascular drainage of amyloid- beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol 2008; 18: 253-266.
8. Weller RO, Boche D, Nicoll JA: Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol 2009; 118: 87-102.
9. Wilhelmus MM, Otte-Holler I, van Triel JJ, Veerhuis R, Maat-Schieman ML, Bu G, de Waal RM, Verbeek MM: Lipoprotein receptor- related protein-1 mediates amyloid-betamediated cell death of cerebrovascular cells. Am J Pathol 2007; 171: 1989-1999.
10. Greenberg CS, Birckbichler PJ, Rice RH: Transglutaminases: multifunctional crosslinking enzymes that stabilize tissues. FASEB J 1991; 5: 3071-3077.
11. Lorand L, Conrad SM: Transglutaminases. Mol Cell Biochem 1984; 58: 9-35.
12. Telci D, Wang Z, Li X, Verderio EA, Humphries MJ, Baccarini M, Basaga H, Griffin M: Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J Biol Chem 2008; 283: 20937-20947.
13. Wilhelmus MM, van Dam AM, Drukarch B: Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases. Eur J Pharmacol 2008; 585: 464-472.
14. Johnson GV, Cox TM, Lockhart JP, Zinnerman MD, Miller ML, Powers RE: Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res 1997; 751: 323-329.
15. Hartley DM, Zhao C, Speier AC, Woodard GA, Li S, Li Z, Walz T: Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiation. J Biol Chem 2008; 283: 16790-16800.
16. Wilhelmus MM, Grunberg SC, Bol JG, van Dam AM, Hoozemans JJ, Rozemuller AJ, Drukarch B: Transglutaminases and transglutaminase- catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain. Brain Pathol 2009; 19: 612-622.
17. Bakker EN, Pistea A, VanBavel E: Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J Vasc Res 2008; 45: 271-278.
18. Verhaar R, Jongenelen CA, Gerard M, Baekelandt V, van Dam AM, Wilhelmus M, Drukarch B: Blockade of enzyme activity inhibits tissue transglutaminase- mediated transamidation of alpha-synuclein in a cellular model of Parkinson's disease. Neurochem Int 2011; 58: 785-793.